FDA Takes a Closer Look at Insulin Pumps
March 9th, 2010 admin
Topics:
This past week, the Wall Street Journal reported that the FDA is investigating the stability of pumps for diabetes management. The concern arises from the possibility of misuse by the patient and less likely a pump defect. Within a five year period, there have been 18 recalls and 17,000 reports of health problems. The FDA is not focused on one company in particular, but pump
Related Posts
The New York Times reports on health in the U.S. “The percentage of people who reported having excellent or very good health declined to 66.6 percent in the 2009 period, from 69.1 percent in 1998. Americans report that they have been exercising more. Nevertheless, more than a quarter were obese in 2009 (with a body mass index of 30 or more),...
A new evidence review suggests that using a pump to deliver insulin continuously instead of taking three or more daily injections might result in better control of blood sugar for people with type 1 diabetes. “The findings of this review tell us that both continuous subcutaneous insulin infusion and multiple injections correct blood glucose...
Last month, a friend of mine had to build a website for a class project, and the site focused on people with diabetes who had multiple health problems. I was really struck by the title and slogan that she came up with for the project; it was “Diabetes Plus: because it’s rarely just diabetes.”
Read More →
You heard of Medingo, right? The Israeli start-up company whose new patch pump technology was recently acquired by Accu-Chek/Roche Diabetes? Well, there’s another Israeli start-up that’s presumably hoping to beat a similar path. The company is called NiliMedix, based in the country’s Haifa District. They’re developing both...
Today, Sanofi-Aventis announced that it’s getting into the glucose meter manufacturing business, by partnering with a small company known for highly accurate meter technology, AgaMatrix (makers of WaveSense products, based on a patented electrochemistry formula). Reports say the new Sanofi-branded meters will be out later this year, and that...
Once a year my company offers health screenings — free — and an incentive (such as a gift card) for taking the health screening. I think it’s a great idea for companies to do this because there are plenty of stories about people who don’t go to the doctor enough and then go through a health screening at work and discover that...
If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says,
Read More →
Children’s prescription drug use rose “several times faster” than adult use last year, “due in part to swine flu drugs and Type 2 diabetes medications, according to Medco Health Solutions Inc,” The Associated Press reports. The “pharmacy benefits manager said a 5 percent increase in prescription drug use for children...
The growing use of insulin delivery devices such as pens and pumps may help individuals with diabetes optimize blood glucose control and minimize their risk for chronic health problems associated with diabetes, as described in a Special Supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc....
Adults and children with diabetes who used the Medtronic MiniMed Paradigm® REAL-Time System achieved better glucose control without hypoglycemia increase compared to patients using multiple daily insulin injections, in the longest and largest randomized, controlled study of sensor-augmented insulin pump therapy in type 1 diabetes…
Read More →
Related Tweets from Twitter
Related News from Digg
Leave a comment
| Trackback
